Environmental Nonessential Element Exposure and Urologic Cancer: A Systematic Review and Meta-Analysis - Top-Institutions - MDSpire

Environmental Nonessential Element Exposure and Urologic Cancer: A Systematic Review and Meta-Analysis

  • By

  • Zhengyi Deng

  • Jinhui Li

  • Renyue Ji

  • Juan Ramon Delgado

  • Steve H. L. Yim

  • Linda Kachuri

  • Andres Cardenas

  • Rebecca E. Graff

  • John T. Leppert

  • Leslie K. Dennis

  • Benjamin I. Chung

  • Marvin E. Langston

  • May 22, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Johns Hopkins School of Medicine
    Johns Hopkins School of Medicine

    Baltimore, Maryland

    Key Differentiators

    • Urology
    • Oncology

  • #2

    Dana-Farber Brigham Cancer Center
    Dana-Farber Brigham Cancer Center

    Boston, Massachusetts

    Key Differentiators

    • Urology
    • Oncology

  • #3

    National Cancer Institute
    National Cancer Institute

    Bethesda, Maryland

    Key Differentiators

    • Oncology
    • Public Health

  • #4

    University of California, San Francisco
    University of California, San Francisco

    San Francisco, California

    Key Differentiators

    • Urology
    • Oncology

  • #5

    China Medical University Hospital
    China Medical University Hospital

    Taichung, Taiwan

    Key Differentiators

    • Urology
    • Public Health

Original Source(s)

Environmental Nonessential Element Exposure and Urologic Cancer: A Systematic Review and Meta-Analysis

  • by Zhengyi Deng, Jinhui Li, Renyue Ji, Juan Ramon Delgado, Steve H. L. Yim, Linda Kachuri, Andres Cardenas, Rebecca E. Graff, John T. Leppert, Leslie K. Dennis, Benjamin I. Chung, Marvin E. Langston

  • May 22, 2026

Related Content

Use of PCSK9 Inhibitors Among Patients Receiving Immune Checkpoint Inhibitors for Cancer

Recurrent pleuropulmonary blastoma type III initially misclassified as embryonal rhabdomyosarcoma on limited biopsy: a case report with pathogenic DICER1 variant

Identification of MTMR2 as an AML-associated candidate biomarker derived from lipid metabolism–related transcriptomic analysis